69 related articles for article (PubMed ID: 17161985)
1. Enhanced cytotoxicity of RIPTK gene therapy of pancreatic cancer via PDX-1 co-delivery.
Liu S; Wang XP; Brunicardi FC
J Surg Res; 2007 Jan; 137(1):1-9. PubMed ID: 17161985
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxic gene therapy for human breast cancer in vitro.
Levy S; Zhou B; Ballian N; Li Z; Liu SH; Feanny M; Wang XP; Blanchard DK; Brunicardi FC
J Surg Res; 2006 Nov; 136(1):154-60. PubMed ID: 17007882
[TBL] [Abstract][Full Text] [Related]
3. Establishment of a non-invasive mouse reporter model for monitoring in vivo pdx-1 promoter activity.
Shiraiwa T; Kaneto H; Miyatsuka T; Kato K; Yamamoto K; Kawashima A; Kajimoto Y; Matsuoka TA; Matsuhisa M; Yamasaki Y; Fujitani Y
Biochem Biophys Res Commun; 2007 Sep; 361(3):739-44. PubMed ID: 17678877
[TBL] [Abstract][Full Text] [Related]
4. Effective ablation of pancreatic cancer cells in SCID mice using systemic adenoviral RIP-TK/GCV gene therapy.
Liu SH; Davis A; Li Z; Ballian N; Davis E; Wang XP; Fisher W; Brunicardi FC
J Surg Res; 2007 Jul; 141(1):45-52. PubMed ID: 17512546
[TBL] [Abstract][Full Text] [Related]
5. Combination of cytosine deaminase suicide gene expression with DR5 antibody treatment increases cancer cell cytotoxicity.
Kaliberov SA; Chiz S; Kaliberova LN; Krendelchtchikova V; Della Manna D; Zhou T; Buchsbaum DJ
Cancer Gene Ther; 2006 Feb; 13(2):203-14. PubMed ID: 16082379
[TBL] [Abstract][Full Text] [Related]
6. Combined suicide gene therapy for pancreatic peritoneal carcinomatosis using BGTC liposomes.
Hajri A; Wack S; Lehn P; Vigneron JP; Lehn JM; Marescaux J; Aprahamian M
Cancer Gene Ther; 2004 Jan; 11(1):16-27. PubMed ID: 14681723
[TBL] [Abstract][Full Text] [Related]
7. Cell-specific cytotoxicity of human pancreatic adenocarcinoma cells using rat insulin promoter thymidine kinase-directed gene therapy.
Tirone TA; Wang XP; Templeton NS; Lee T; Nguyen L; Fisher W; Brunicardi FC
World J Surg; 2004 Aug; 28(8):826-33. PubMed ID: 15457366
[TBL] [Abstract][Full Text] [Related]
8. p51/p63, a novel p53 homologue, potentiates p53 activity and is a human cancer gene therapy candidate.
Kunisaki R; Ikawa S; Maeda T; Nakazaki Y; Kurita R; Harata M; Shutoh Y; Bai YS; Soda Y; Tanabe T; Dohi T; Kato R; Ikawa Y; Asano S; Tani K
J Gene Med; 2006 Sep; 8(9):1121-30. PubMed ID: 16832836
[TBL] [Abstract][Full Text] [Related]
9. PDX-1 acts as a potential molecular target for treatment of human pancreatic cancer.
Liu S; Ballian N; Belaguli NS; Patel S; Li M; Templeton NS; Gingras MC; Gibbs R; Fisher W; Brunicardi FC
Pancreas; 2008 Aug; 37(2):210-20. PubMed ID: 18665085
[TBL] [Abstract][Full Text] [Related]
10. Ectopic PDX-1 expression in liver ameliorates type 1 diabetes.
Shternhall-Ron K; Quintana FJ; Perl S; Meivar-Levy I; Barshack I; Cohen IR; Ferber S
J Autoimmun; 2007; 28(2-3):134-42. PubMed ID: 17383157
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional targeting of virus-mediated gene transfer by the human hexokinase II promoter.
Määttä AM; Korja S; Venhoranta H; Hakkarainen T; Pirinen E; Heikkinen S; Pellinen R; Mäkinen K; Wahlfors J
Int J Mol Med; 2006 Nov; 18(5):901-8. PubMed ID: 17016620
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional tumor-selective promoter targeting of E. coli purine nucleoside phosphorylase for pancreatic cancer suicide gene therapy.
Deharvengt S; Wack S; Aprahamian M; Hajri A
J Gene Med; 2005 May; 7(5):672-80. PubMed ID: 15580629
[TBL] [Abstract][Full Text] [Related]
13. beta-cell neogenesis induced by adenovirus-mediated gene delivery of transcription factor pdx-1 into mouse pancreas.
Taniguchi H; Yamato E; Tashiro F; Ikegami H; Ogihara T; Miyazaki J
Gene Ther; 2003 Jan; 10(1):15-23. PubMed ID: 12525833
[TBL] [Abstract][Full Text] [Related]
14. Pdx-1 modulates histone H4 acetylation and insulin gene expression in terminally differentiated alpha-TC-1 cells.
Wang HW; Breslin MB; Lan MS
Pancreas; 2007 Mar; 34(2):248-53. PubMed ID: 17312465
[TBL] [Abstract][Full Text] [Related]
15. Specific gene expression and therapy for pancreatic cancer using the cytosine deaminase gene directed by the rat insulin promoter.
Wang XP; Yazawa K; Yang J; Kohn D; Fisher WE; Brunicardi FC
J Gastrointest Surg; 2004 Jan; 8(1):98-108; discussion 106-8. PubMed ID: 14746841
[TBL] [Abstract][Full Text] [Related]
16. Specific targeting of pancreatic islet cells in vivo by insulin-promoter-driven adenoviral conjugated reporter genes.
Wang X; Olmsted-Davis E; Davis A; Liu S; Li Z; Yang J; Brunicardi FC
World J Surg; 2006 Aug; 30(8):1543-52. PubMed ID: 16855800
[TBL] [Abstract][Full Text] [Related]
17. Radiation enhances adenoviral gene therapy in pancreatic cancer via activation of cytomegalovirus promoter and increased adenovirus uptake.
Egami T; Ohuchida K; Mizumoto K; Onimaru M; Toma H; Nishio S; Nagai E; Matsumoto K; Nakamura T; Tanaka M
Clin Cancer Res; 2008 Mar; 14(6):1859-67. PubMed ID: 18347189
[TBL] [Abstract][Full Text] [Related]
18. Killer genes in pancreatic cancer therapy.
Fogar P; Greco E; Basso D; Navaglia F; Plebani M; Pedrazzoli S
Cell Mol Biol (Noisy-le-grand); 2005 Sep; 51(1):61-76. PubMed ID: 16171565
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of promoters for driving efficient transgene expression in neonatal porcine islets.
Londrigan SL; Brady JL; Sutherland RM; Hawthorne WJ; Thomas HE; Jhala G; Cowan PJ; Kay TW; O'Connell PJ; Lew AM
Xenotransplantation; 2007 Mar; 14(2):119-25. PubMed ID: 17381686
[TBL] [Abstract][Full Text] [Related]
20. Tumor growth suppression by adenovirus-mediated introduction of a cell-growth-suppressing gene tob in a pancreatic cancer model.
Yanagie H; Tanabe T; Sumimoto H; Sugiyama H; Matsuda S; Nonaka Y; Ogiwara N; Sasaki K; Tani K; Takamoto S; Takahashi H; Eriguchi M
Biomed Pharmacother; 2009 May; 63(4):275-86. PubMed ID: 18657378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
